Brief: Microba Life Sciences Says FY25 Revenue A$15.67M
22/07/2025 02:15
July 22 (Reuters) - Microba Life Sciences Ltd MAP.AX: Q4 FY25 QUARTERLY ACTIVITIES REPORT & APPENDIX 4C FY25 REVENUE A$15.67M Further company coverage: MAP.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microba Life Sciences
See all newsAustralia's Microba Life Sciences slumps to record low on discounted placement
Brief: Microba Life Sciences Secures A$5 Million Placement At A$0.05 Per Share
Brief: Microba Life Sciences Seeks Trading Halt
Brief: Microba Life Sciences Logs Qtrly Total Revenue A$3.36 Mln
Brief: Microba Life Sciences Posts HY Loss Attributable A$10.6 Million